HCmed Innovations Co., Ltd., a contract development and manufacturing organization (CDMO), is delighted to announce the appointment of Gunilla Petersson, Ph.D. as its new Chief Scientific Officer (CSO).
In this new position, Dr. Petersson will help drive HCmed’s strategic business development and provide expert advice on the development of combination products. With her knowledge and experience, she will be instrumental in helping HCmed reach its goals and expand its capabilities.
Dr. Petersson brings over 29 years of experience in the pharmaceutical industry to HCmed, with a special focus on innovation strategies and internal liaison. She has created strong connections with several global pharmaceutical companies and renowned experts in the field, and has become an expert in novel technology scouting and due diligence activities. Her impressive career has also seen her excel in scientific marketing, making her an invaluable addition to the HCmed team.
Gunilla is the perfect addition to the HCmed team! Her immense experience and success in developing inhaled combination products, along with her knowledge of international business operations, make her an invaluable asset.
We are confident that Gunilla’s leadership will help HCmed expand our business opportunities, bringing many benefits to HCmed and our pharmaceutical partners. Chairman Jason Cheng is thrilled to have her join the team.
Dr. Petersson is a proud holder of a doctoral degree in Analytical Chemistry from the esteemed Lund University in Sweden. With years of experience in the field and deep knowledge of the subject, she is a valuable asset to the world of science.
At HCmed Innovations Co., Ltd., we are revolutionizing the way drugs are delivered to patients. Established in 2014, we are a contract development and manufacturing organization that specializes in vibrating mesh nebulizer technology.
Our platform is designed to enhance drug delivery by efficiently and reliably nebulizing different types of medication, ranging from small molecule synthetics to large molecule biologics. We are committed to providing our pharmaceutical partners with high-quality, cost-effective solutions for inhalation therapy.
Our customizable mesh nebulizer platform is the perfect solution to make sure your drugs get where they need to go safely and quickly. We are proud to be pioneers in the field of drug delivery.